Author:
Kim Richard,Chiorean E Gabriela,Amin Manik,Rocha-Lima Caio Max S,Gandhi Jitendra,Harris William P,Song Tao,Portnoy David
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Albores-Saavedra J, Schwartz AM, Batich K, Henson DE (2009) Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 100: 598–605.
2. Brooks DP, DePalma PD, Pullen M, Gellai M, Nambi P (1995) Identification and function of putative ETB receptor subtypes in the dog kidney. J Cardiovasc Pharmacol 26: S322–S325.
3. The Christie NHS Foundation Trust. Active symptom control alone or with mFOLFOX chemotherapy for locally advanced/metastatic biliary tract cancers (ABC06). NCT01926236. Available at https://clinicaltrials.gov/ct2/show/NCT01926236 (accessed on 10 April 2017).
4. Goyal L, Zheng H, Yurgelun MB, Abrams TA, Allen JN, Cleary JM, Knowles M, Regan E, Reardon A, Khachatryan A, Jain RK, Nardi V, Borger DR, Duda DG, Zhu AX (2017) A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer 123 (11): 1979–1988.
5. Guion-Dussere JF, Lorgis V, Vincent J, Bengrine L, Ghiringhelli F (2015) FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma. World J Gastroenterol 21: 2096–2101.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献